logo
logo
Sign in

Ovarian Cancer Market, Pipeline, Industry Analysis, Drugs, Pipeline, Treatment and Key Companies by DelveInsight

avatar
Ankit Nigam
Ovarian Cancer Market, Pipeline, Industry Analysis, Drugs, Pipeline, Treatment and Key Companies by DelveInsight

DelveInsight's "Ovarian Cancer Market Insights, Epidemiology, and Market Forecast-2030" report delivers an in-depth understanding of the Ovarian Cancer, historical and forecasted epidemiology as well as the Ovarian Cancer market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

View Report: https://www.delveinsight.com/report-store/ovarian-cancer-market

Some key facts of Ovarian Cancer Market are:

·        The rate of new cases of ovarian cancer was 11.2 per 100,000 women per year.

·        The death rate was 6.7 per 100,000 women per year. These rates are age-adjusted and based on 2013–2017 cases and 2014–2018 deaths.

·        Approximately 1.2 percent of women will be diagnosed with ovarian cancer at some point during their lifetime, based on 2015–2017 data.

·        In 2017, there were an estimated 233,364 women living with ovarian cancer in the United States.

·        The earlier ovarian cancer is caught, the better chance a person has of surviving five years after being diagnosed. For ovarian cancer, 15.7% are diagnosed at the local stage. The 5-year relative survival for localized ovarian cancer is 92.6%.

View Report: https://www.delveinsight.com/report-store/ovarian-cancer-market

Ovarian Cancer Companies are:

·        Celsion

·        Oncology Venture

·        ImmunoVaccine Technologies

·        OncoQuest

·        Harpoon Therapeutics

·        Immunogen

·        Shattuck Labs

·        Precigen

·        Roche

·        Ellipses Pharma

·        Artios Pharma

·        And Many Others

View Report: https://www.delveinsight.com/report-store/ovarian-cancer-market

Ovarian Cancer Therapies:

·        GEN-1

·        2X-121

·        PXSurvivac

·        Oregovomab

·        HPN536

·        Mirvetuximab soravtansine (IMGN853)

·        SL-172154

·        PRGN-3005 UltraCAR-T

·        Ipatasertib and Rucaparib combination

·        EP0057

·        ART0380

·        And Many Others

View Report: https://www.delveinsight.com/report-store/ovarian-cancer-market

Related Reports:

About Delveinsight: 

DelveInsight Business Research is a leading Market Research, and Business Consultant focused purely on Healthcare. It helps pharma companies by providing them with end-to-end services to solve their business problems.

Get hold of all the Pharma and healthcare market research reports on our market research subscription-based platform PharmDelve.

 

collect
0
avatar
Ankit Nigam
guide
Zupyak is the world’s largest content marketing community, with over 400 000 members and 3 million articles. Explore and get your content discovered.
Read more